Antag Therapeutics

Biotechnology Research • Copenhagen, Capital Region of Denmark, Denmark • 21-50 Employees

Company overview

Headquarters	Blegdamsvej 3b, Copenhagen, Nørrebro 2200, DK
Phone number	+4521456537
Websites	antagtherapeutics.com antagtx.com
Founded	2017
Employees	21-50
Socials

Key Contacts at Antag Therapeutics

Joerg Moeller

Chief Executive Officer

Alexander Sparre-Ulrich

Chief Operating Officer And Co-Founder

Ayna Nejad

Director. Head Of Clinical Pharmacology

Mette Høy Jensen

Director Scientific Affairs

Antag Therapeutics Email Formats

Antag Therapeutics uses 1 email format. The most common is {2char} (e.g., {2char}@antagtherapeutics.com), used 100% of the time.

Format	Example	Percentage
{2char}	{2char}@antagtherapeutics.com	100%

About Antag Therapeutics

Antag Therapeutics is a biotechnology company pioneering personal and flexible obesity treatment through GIP receptor antagonism. Antag’s lead molecule AT-7687 is specifically designed to target and deactivate the GIP receptor, a genetically-validated pathway that contributes to fat storage, insulin resistance, and metabolic dysfunction – and is mechanistically distinct from GLP-1 therapies. Antag’s GIPR antagonist approach stems from the work of the esteemed research teams of Professors Jens Juul Holst and Mette Rosenkilde, two co-founders of the business. Antag’s vision is that all people living with obesity, diabetes and overweight have a personal treatment option that goes beyond weight loss to improve long-term health, without having to compromise on tolerability.

Antag Therapeutics revenue & valuation

Annual revenue	$2,500,000
Revenue per employee	$114,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,000,000
Total funding	$87,700,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Vice President

C-Suite

Director

Employees by Department

Antag Therapeutics has 6 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Antag Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-07-03	1	$3,600,000
2025-01-04	4	$84,100,000

Funding Insights

$87,700,000

Total funding amount

$84,100,000

Most recent funding amount

Number of funding rounds

Antag Therapeutics Tech Stack

Discover the technologies and tools that power Antag Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

LiteSpeed

Web servers

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Umami

Analytics

MySQL

Databases

RSS

Miscellaneous

Google Font API

Font scripts

jQuery Migrate

JavaScript libraries

Frequently asked questions

Antag Therapeutics is located in Copenhagen, Capital Region of Denmark, DK.

You can reach Antag Therapeutics at +4521456537.

Antag Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Antag Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Antag Therapeutics has raised a total of $87,700,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.